Cargando…
Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes
Cancer cachexia (CC), characterized by body weight loss and sarcopenia, contributes to over 20% of all cancer-related death. Approximately 80% of pancreatic cancer (PC) patients develop CC during disease progression. Pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, IL-8, and tumor ne...
Autores principales: | Hou, Ya-Chin, Wang, Chih-Jung, Chao, Ying-Jui, Chen, Hao-Yun, Wang, Hao-Chen, Tung, Hui-Ling, Lin, Jung-Ting, Shan, Yan-Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306800/ https://www.ncbi.nlm.nih.gov/pubmed/30513776 http://dx.doi.org/10.3390/jcm7120502 |
Ejemplares similares
-
The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer
por: Hou, Ya-Chin, et al.
Publicado: (2022) -
Emerging markers of cancer cachexia and their relationship to sarcopenia
por: Lipshitz, Melanie, et al.
Publicado: (2023) -
Relationship between pancreatic cancer‐associated diabetes and cachexia
por: Liao, Wei‐Chih, et al.
Publicado: (2020) -
Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
por: Hou, Ya-Chin, et al.
Publicado: (2014) -
Phase Angle as an Indicator of Sarcopenia, Malnutrition, and Cachexia in Inpatients with Cardiovascular Diseases
por: Hirose, Suguru, et al.
Publicado: (2020)